Therefore, although further work is needed to verify the effectiveness of SCGF-β, VEGF, and LIF in treatment of retinal diseases, sustainably increased secretion of these factors in our coculture systems suggests them to be potential targets for regenerative therapies for retinal photoreceptor neurons. The gene discussed is VEGFA; the disease is Abnormal retinal morphology.